Latin America Investor Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.

Press releases published on September 9, 2026

Sep. 9, 2026

Intermediate Bulk Container Market (IBC) Competitive Insights, Demand Analysis

Indeterminate GlobeNewswire

Sep. 9, 2026

Gron Ventures and Red Tech Obtain $61.5 Million Arbitration Award Against Berner's Cookies for Fraud, Intentional Interference and Breach of Contract

Indeterminate GlobeNewswire

Sep. 9, 2026

YYZLabs Capital Strengthens Singapore Base to Capture Global Private Market Opportunities

Indeterminate GlobeNewswire

Sep. 9, 2026

Flexible Packaging Market Size Demand Competitive Insights

Indeterminate GlobeNewswire

Sep. 9, 2026

Crypto News: Pepeto Announces Presale Stage Near Sellout Following Dogecoin Success While the Bitcoin Price Prediction Jumps to $250,000

Indeterminate GlobeNewswire

Sep. 9, 2026

Forward Industries Urges Shareholders of SkyAI to Vote No at the 2026 Annual Meeting

Indeterminate GlobeNewswire

Sep. 9, 2026

HIZERO Takes an Exciting Leap Forward at IFA 2026, Sparking a Surge of Interest in Its Broadened No Suction Technology™ Range

Indeterminate GlobeNewswire

Sep. 9, 2026

Ladies of Porter Ranch Partners with American Red Cross for Community Blood Drive During Sickle Cell Awareness Month

Indeterminate GlobeNewswire

Sep. 9, 2026

Upcomers Payouts Reach Record $1.85M in August, Exceeding $3.5M Over Two Months

Indeterminate GlobeNewswire

Sep. 9, 2026

2026 Kantar BrandZ Top 100 Most Valuable Chinese Brands unveiled: seven new entrants join the ranking as total brand value grows by 13%

Indeterminate GlobeNewswire

Sep. 9, 2026

OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients

Indeterminate GlobeNewswire

Sep. 9, 2026

OSE Immunotherapeutics se félicite de l’inclusion du premier patient traité par Veloxis dans l’étude de phase 2 RENGEVITY-201 évaluant le pegrizeprument (VEL-101) dans la prévention du rejet d’organe chez les patients transplantés rénaux

Indeterminate GlobeNewswire

Sep. 9, 2026

Meridian launches Categorization Agent to power accurate accrual-basis books in the automated close

Indeterminate GlobeNewswire

Sep. 9, 2026

Carahsoft and Sonar Expand Partnership to Deliver AI Code Verification and Governance Across All North American Markets

Indeterminate GlobeNewswire

Sep. 9, 2026

National Advertising Division Will Refer Genspark to the Federal Trade Commission for Failure to Respond to Inquiry

Indeterminate GlobeNewswire

Sep. 9, 2026

Four Biotech Stories Heating Up Right Now

Indeterminate GlobeNewswire

Sep. 9, 2026

Verizon declares quarterly dividend on September 9, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

DealHub MCP Brings Agentic Control to Quote-to-Revenue

Indeterminate GlobeNewswire

Sep. 9, 2026

PPB Capital Partners Accelerates Growth and Vision with the Hiring of Two Nationally Known Wealth Management Professionals

Indeterminate GlobeNewswire

Sep. 9, 2026

ISMG Acquires INE to Advance Global Cyber Readiness Across Every Discipline and Role

Indeterminate GlobeNewswire